Multiple Sclerosis (MS) is a debilitating neurological disease which affects 80,000 individuals in France. At the moment, there is no known cause or cure. There are only treatments for the disease symptoms. Given the need to keep patients informed of progress in research, Inserm and Fondation ARSEP organise national meetings between researchers and patients every two years.
Rendez-vous du 17 au 19 octobre 2013 Place Carrée au Forum des Halles pour « Sciences au Carré(e) »Un événement grand public, gratuit et innovant proposé par les principaux organismes de recherche français pour éveiller la curiosité scientifique !
A l’occasion de la journée mondiale de la maladie d’Alzheimer qui se tiendra le 21 septembre 2013, le service de presse de l’Inserm vous compile les dernières actualités/avancées sur cette maladie.
In the Web 2.0 and “Quantified Self” era, scientists are working to improve traditional data collection methods (face-to-face interviews, telephone interviews or paper questionnaires), which are expensive and time-consuming for study participants. Indeed, recruitment, monitoring and data collection tools need to be adapted to fit the habits of the younger generation. The Internet and smartphones offer numerous options for collecting data on participants’ lifestyle, environment and health, in a...
L'Inserm et Universcience vous invitent à la conférence Santé en questions, le mercredi 19 juin, sur la drépanocytose, les voies de la guérison.
A l’occasion du comité de suivi annuel du schéma national pour les handicaps rares qui s’est tenu le 30 avril 2013, et a été présidé par Mme Marie-Arlette Carlotti, Ministre chargée des personnes handicapées et de la lutte contre l'exclusion, l’Inserm rend publique l’expertise collective « Handicaps rares, contextes, enjeux et perspectives. »
Hervé Chneiweiss, a research director at the CNRS, has just been appointed President of the Inserm Ethics Committee. Inserm's Ethics Committee for medical research and health was set up in 2000 with the aim of playing an active part in the dialogue between Society and the scientific and medical communities.
André Syrota has been reappointed by the French government as Chairman and CEO of the National Institute of Health and Medical Research (Inserm), on the recommendation of the Minister for Higher Education and Research, Geneviève Fioraso.
L’Inserm et l’Université Toulouse III - Paul Sabatier renouvellent leur partenariat en matière de recherche, de valorisation et de transfert de connaissances en sciences du vivant.
In conjunction with the Senate Commission for Social Affairs, Inserm has organised the 6th meeting between national research representatives and patient associations, to be held on Thursday, 31 January 2013. More than twenty researchers and association representatives will provide first-hand accounts and develop dialogue with the senators in front of more than 250 participants. During this event, the results of a large survey conducted on some 600 researchers from...
